<Record>
<Term>Ixabepilone</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Epothilone B Analogue</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Antimitotic Agent/Tubulin Binding Agent/Taxane-Pocket Binding Agent/Epothilone B Analogue/Ixabepilone</ClassificationPath>
<BroaderTerm>Taxane-Pocket Binding Agent</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Ixabepilone</BroaderTerm>
<BroaderTerm>Antimitotic Agent</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Epothilone B Analogue</BroaderTerm>
<BroaderTerm>Tubulin Binding Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Ixempra Kit</Synonym>
<Synonym>IXABEPILONE</Synonym>
<Synonym>BMS 247550</Synonym>
<Synonym>BMS247550</Synonym>
<Synonym>Ixabepilone</Synonym>
<Synonym>Epothilone-B BMS 247550</Synonym>
<Synonym>Ixempra</Synonym>
<Synonym>BMS-247550</Synonym>
<Synonym>(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione</Synonym>
<Synonym>Epothilone</Synonym>
<Synonym>Azaepothilone B</Synonym>
<Description>An orally bioavailable semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arresting cells in the G2-M phase of the cell cycle and inducing tumor cell apoptosis. This agent demonstrates antineoplastic activity against taxane-resistant cell lines.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
